Lisa Salberg and Dr. Marty Maron break down new research reshaping how HCM is treated, from long-standing beta blockers to emerging targeted therapies. They also walk through arrhythmia risks, monitoring, and prevention—giving patients a clearer roadmap for managing symptoms and long-term outcomes in a rapidly changing care landscape.